Merrimack Pharmaceuticals Announces MM-398 Achieves Primary Endpoint of Overall Survival in Phase 3 Trial in Post-Gemcitabine Metastatic

... Read more

Metanor Hits Multiple Gold-Bearing Shear Zones at Barry; Intercepted 14.5 g/t

... Read more

Mettrum Health Corporation

... Read more

Microbix Consults with FDA Regarding Plans for Kinlytic(R)

... Read more

MicroVision to Supply UPS with Custom PicoP® Display Modules for Package Guidance Application

... Read more

MicroVision and Major

... Read more

MicroVision Receives First Order for Small Form Factor Display Engine for $6.7

... Read more

Milestone Scientific Announces 510(k) FDA Clearance for CompuFlo(R)

... Read more

Millrock and First Quantum

... Read more

Millrock and First Quantum

... Read more